• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

戈谢病的血液学特点

Gaucher Disease for Hematologists.

机构信息

İstinye University Faculty of Medicine, Department of Pediatric Hematology Oncology, İstanbul, Turkey

Eskisehir Osmangazi University Faculty of Medicine, Department of Hematology, Eskişehir, Turkey

出版信息

Turk J Haematol. 2022 Jun 1;39(2):136-139. doi: 10.4274/tjh.galenos.2021.2021.0683. Epub 2022 Apr 20.

DOI:10.4274/tjh.galenos.2021.2021.0683
PMID:35439918
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9160697/
Abstract

Gaucher disease (GD) is a rare hereditary lysosomal storage disease that arises due to deficiency of glucocerebrosidase. Early diagnosis is very important for starting proper treatment and preventing complications. Splenomegaly, anemia, and thrombocytopenia are the most common findings in GD and so most patients are initially referred to hematologists. The Turkish Society of Hematology established its Rare Hematological Diseases Subcommittee in 2015. One of the main topics of this subcommittee was to increase and improve awareness and education of rare diseases among hematologists in Turkey. This review presents GD with an overview of its clinical features, pathophysiology, and treatment options for hematologists.

摘要

戈谢病(GD)是一种罕见的遗传性溶酶体贮积病,由于葡萄糖脑苷脂酶的缺乏而引起。早期诊断对于开始适当的治疗和预防并发症非常重要。脾肿大、贫血和血小板减少是 GD 最常见的表现,因此大多数患者最初被转介给血液科医生。土耳其血液学会于 2015 年成立了罕见血液疾病小组委员会。该小组委员会的主要议题之一是提高和加强土耳其血液科医生对罕见疾病的认识和教育。这篇综述介绍了 GD,概述了其临床特征、病理生理学和治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc19/9160697/7af3dafe84ee/TJH-39-136-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc19/9160697/7af3dafe84ee/TJH-39-136-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc19/9160697/7af3dafe84ee/TJH-39-136-g4.jpg

相似文献

1
Gaucher Disease for Hematologists.戈谢病的血液学特点
Turk J Haematol. 2022 Jun 1;39(2):136-139. doi: 10.4274/tjh.galenos.2021.2021.0683. Epub 2022 Apr 20.
2
Hematological manifestations and complications of Gaucher disease.戈谢病的血液学表现和并发症。
Expert Rev Hematol. 2021 Apr;14(4):347-354. doi: 10.1080/17474086.2021.1908120. Epub 2021 Mar 31.
3
Gaucher disease: A cause of massive splenomegaly in a 15-year-old black African male.戈谢病:导致一名 15 岁黑人男性巨脾的病因。
S Afr Med J. 2022 Feb 2;112(1):13515.
4
[Hematological aspects of Gaucher disease].[戈谢病的血液学方面]
Rev Med Interne. 2007 Oct;28 Suppl 2:S176-9. doi: 10.1016/s0248-8663(07)78877-x.
5
Two delayed-diagnosis case reports of long-lasting thrombocytopenia with splenomegaly.两例迟发性血小板增多伴脾肿大的病例报告。
Medicine (Baltimore). 2024 Aug 23;103(34):e39354. doi: 10.1097/MD.0000000000039354.
6
Gaucher Disease: Clinical, Biological and Therapeutic Aspects.戈谢病:临床、生物学及治疗方面
Pathobiology. 2016;83(1):13-23. doi: 10.1159/000440865. Epub 2015 Nov 21.
7
GAU-PED study for early diagnosis of Gaucher disease in children with splenomegaly and cytopenia.GAU-PED 研究:用于诊断脾肿大伴血细胞减少的儿童戈谢病的早期检测。
Orphanet J Rare Dis. 2023 Jun 16;18(1):151. doi: 10.1186/s13023-023-02760-z.
8
Gaucher disease: haematological presentations and complications.戈谢病:血液学表现及并发症。
Br J Haematol. 2014 May;165(4):427-40. doi: 10.1111/bjh.12804. Epub 2014 Mar 3.
9
The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis.887名儿童诊断时非神经病变型戈谢病的临床和人口统计学特征。
Arch Pediatr Adolesc Med. 2006 Jun;160(6):603-8. doi: 10.1001/archpedi.160.6.603.
10
[Gaucher disease type I diagnosed at 63 years old presenting with thrombocytopenia].63岁诊断为I型戈谢病,表现为血小板减少症
Rinsho Ketsueki. 2008 May;49(5):335-9.

引用本文的文献

1
CRISPR/Cas-Based Ex Vivo Gene Therapy and Lysosomal Storage Disorders: A Perspective Beyond Cas9.基于CRISPR/Cas的体外基因治疗与溶酶体贮积症:超越Cas9的视角
Cells. 2025 Jul 25;14(15):1147. doi: 10.3390/cells14151147.
2
Diagnosis and genetic analysis of Gaucher disease in a pediatric case: a case report.小儿戈谢病的诊断与基因分析:一例病例报告
Front Pediatr. 2025 Jul 28;13:1628525. doi: 10.3389/fped.2025.1628525. eCollection 2025.
3
An Overview of Gaucher Disease.戈谢病概述

本文引用的文献

1
ACE phenotyping in Gaucher disease.戈谢氏病中的 ACE 表型。
Mol Genet Metab. 2018 Apr;123(4):501-510. doi: 10.1016/j.ymgme.2018.02.007. Epub 2018 Feb 17.
2
Hematopoietic stem cell transplantation for Gaucher disease.戈谢病的造血干细胞移植
Cochrane Database Syst Rev. 2017 Oct 18;10(10):CD006974. doi: 10.1002/14651858.CD006974.pub4.
3
Reductions in glucosylsphingosine (lyso-Gb1) in treatment-naïve and previously treated patients receiving velaglucerase alfa for type 1 Gaucher disease: Data from phase 3 clinical trials.
Diagnostics (Basel). 2024 Dec 17;14(24):2840. doi: 10.3390/diagnostics14242840.
4
Adult type I Gaucher disease with splenectomy caused by a compound heterozygous GBA1 mutation in a Chinese patient: a case report.一名中国患者因复合杂合性GBA1突变导致脾切除术后的成人型I型戈谢病:病例报告
Ann Hematol. 2024 May;103(5):1765-1774. doi: 10.1007/s00277-024-05710-2. Epub 2024 Mar 20.
未经治疗和既往治疗的 1 型 Gaucher 病患者接受维拉苷酶阿尔法治疗后葡糖脑苷脂(溶酶体脑苷脂)的减少:来自 3 期临床试验的数据。
Mol Genet Metab. 2017 Sep;122(1-2):113-120. doi: 10.1016/j.ymgme.2017.08.005. Epub 2017 Aug 24.
4
Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy.伊米苷酶用于1型戈谢病的治疗:基于证据对其在治疗中地位的综述
Core Evid. 2016 Oct 14;11:37-47. doi: 10.2147/CE.S93717. eCollection 2016.
5
Gaucher disease epidemiology and natural history: a comprehensive review of the literature.戈谢病的流行病学与自然史:文献综述
Hematology. 2017 Mar;22(2):65-73. doi: 10.1080/10245332.2016.1240391. Epub 2016 Oct 20.
6
Prenatal diagnosis of Gaucher disease using next-generation sequencing.使用下一代测序技术对戈谢病进行产前诊断。
Pediatr Int. 2016 Sep;58(9):946-9. doi: 10.1111/ped.13069.
7
Enzyme Replacement or Substrate Reduction? A Review of Gaucher Disease Treatment Options.酶替代疗法还是底物减少疗法?戈谢病治疗方案综述。
Hosp Pharm. 2016 Jul;51(7):553-63. doi: 10.1310/hpj5107-553.
8
Hyperferritinemia and iron metabolism in Gaucher disease: Potential pathophysiological implications.戈谢病中的高铁蛋白血症与铁代谢:潜在的病理生理学意义
Blood Rev. 2016 Nov;30(6):431-437. doi: 10.1016/j.blre.2016.05.003. Epub 2016 May 27.
9
Hematological manifestations and complications of Gaucher disease.戈谢病的血液学表现及并发症
Expert Rev Hematol. 2016 Jan;9(1):51-8. doi: 10.1586/17474086.2016.1112732. Epub 2015 Nov 13.
10
Long-term treatment outcomes in Gaucher disease.戈谢病的长期治疗结果。
Am J Hematol. 2015 Jul;90 Suppl 1:S19-24. doi: 10.1002/ajh.24056.